74 related articles for article (PubMed ID: 30408479)
1. Exendin-4 improves behaviorial deficits via GLP-1/GLP-1R signaling following partial hepatectomy.
Zhou Y; Li Z; Cao X; Ma H; White PF; Xu X; Jiang Y; Sun X; Cui Y
Brain Res; 2019 Mar; 1706():116-124. PubMed ID: 30408479
[TBL] [Abstract][Full Text] [Related]
2. Increased co-expression of PSMA2 and GLP-1 receptor in cervical cancer models in type 2 diabetes attenuated by Exendin-4: A translational case-control study.
Mao D; Cao H; Shi M; Wang CC; Kwong J; Li JJX; Hou Y; Ming X; Lee HM; Tian XY; Wong CK; Chow E; Kong APS; Lui VWY; Chan PKS; Chan JCN
EBioMedicine; 2021 Mar; 65():103242. PubMed ID: 33684886
[TBL] [Abstract][Full Text] [Related]
3. Acylation of the Incretin Peptide Exendin-4 Directly Impacts Glucagon-Like Peptide-1 Receptor Signaling and Trafficking.
Lucey M; Ashik T; Marzook A; Wang Y; Goulding J; Oishi A; Broichhagen J; Hodson DJ; Minnion J; Elani Y; Jockers R; Briddon SJ; Bloom SR; Tomas A; Jones B
Mol Pharmacol; 2021 Oct; 100(4):319-334. PubMed ID: 34315812
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1.
Marzook A; Chen S; Pickford P; Lucey M; Wang Y; Corrêa IR; Broichhagen J; Hodson DJ; Salem V; Rutter GA; Tan TM; Bloom SR; Tomas A; Jones B
Biochem Pharmacol; 2021 Aug; 190():114656. PubMed ID: 34129856
[TBL] [Abstract][Full Text] [Related]
5. A novel dual agonist of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors attenuates fentanyl taking and seeking in male rats.
Zhang Y; Rahematpura S; Ragnini KH; Moreno A; Stecyk KS; Kahng MW; Milliken BT; Hayes MR; Doyle RP; Schmidt HD
Neuropharmacology; 2021 Jul; 192():108599. PubMed ID: 33965397
[TBL] [Abstract][Full Text] [Related]
6. Effects of repeated developmental GLP-1R agonist exposure on young adult behavior and hippocampal structure in mice.
Cerroni C; Steiner A; Seanez L; Kwon S; Lewis AS
Neurosci Lett; 2023 Jun; 808():137299. PubMed ID: 37196974
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Cardiac Ventricular Excitability by GLP-1 (Glucagon-Like Peptide-1).
Ang R; Mastitskaya S; Hosford PS; Basalay M; Specterman M; Aziz Q; Li Y; Orini M; Taggart P; Lambiase PD; Gourine A; Tinker A; Gourine AV
Circ Arrhythm Electrophysiol; 2018 Oct; 11(10):e006740. PubMed ID: 30354404
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of Dexmedetomidine Intervention on Neurogenic Inflammation in Cognitive Impairment Rats after Partial Hepatectomy.
Zhang Z; Jia H
Comput Math Methods Med; 2022; 2022():8714221. PubMed ID: 36213579
[TBL] [Abstract][Full Text] [Related]
9. Disconnect between signalling potency and in vivo efficacy of pharmacokinetically optimised biased glucagon-like peptide-1 receptor agonists.
Lucey M; Pickford P; Bitsi S; Minnion J; Ungewiss J; Schoeneberg K; Rutter GA; Bloom SR; Tomas A; Jones B
Mol Metab; 2020 Jul; 37():100991. PubMed ID: 32278079
[TBL] [Abstract][Full Text] [Related]
10. A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus.
Botfield HF; Uldall MS; Westgate CSJ; Mitchell JL; Hagen SM; Gonzalez AM; Hodson DJ; Jensen RH; Sinclair AJ
Sci Transl Med; 2017 Aug; 9(404):. PubMed ID: 28835515
[TBL] [Abstract][Full Text] [Related]
11. Exendin-4 Prevents Memory Loss and Neuronal Death in Rats with Sporadic Alzheimer-Like Disease.
Zago AM; Carvalho FB; Rahmeier FL; Santin M; Guimarães GR; Gutierres JM; da C Fernandes M
Mol Neurobiol; 2024 May; 61(5):2631-2652. PubMed ID: 37919602
[TBL] [Abstract][Full Text] [Related]
12. Activation of the CD200/CD200R1 axis attenuates neuroinflammation and improves postoperative cognitive dysfunction via the PI3K/Akt/NF-κB signaling pathway in aged mice.
Qian H; Gao F; Wu X; Lin D; Huang Y; Chen A; Deng J; Gong C; Chen X; Zheng X
Inflamm Res; 2023 Dec; 72(12):2127-2144. PubMed ID: 37902837
[TBL] [Abstract][Full Text] [Related]
13. GLP-1 modulates the supramammillary nucleus-lateral hypothalamic neurocircuit to control ingestive and motivated behavior in a sex divergent manner.
López-Ferreras L; Eerola K; Mishra D; Shevchouk OT; Richard JE; Nilsson FH; Hayes MR; Skibicka KP
Mol Metab; 2019 Feb; 20():178-193. PubMed ID: 30528281
[TBL] [Abstract][Full Text] [Related]
14. Novel GLP-1R/GIPR co-agonist "twincretin" is neuroprotective in cell and rodent models of mild traumatic brain injury.
Tamargo IA; Bader M; Li Y; Yu SJ; Wang Y; Talbot K; DiMarchi RD; Pick CG; Greig NH
Exp Neurol; 2017 Feb; 288():176-186. PubMed ID: 27845037
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin-seeking behavior in rats.
Douton JE; Augusto C; Stoltzfus B; Carkaci-Salli N; Vrana KE; Grigson PS
Behav Pharmacol; 2021 Jun; 32(4):265-277. PubMed ID: 33229892
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 receptor differentially controls mossy cell activity across the dentate gyrus longitudinal axis.
Steiner A; Owen BM; Bauer JP; Seanez L; Kwon S; Biddinger JE; Huffman R; Ayala JE; Nobis WP; Lewis AS
Hippocampus; 2022 Nov; 32(11-12):797-807. PubMed ID: 36063105
[TBL] [Abstract][Full Text] [Related]
17. Control of human pancreatic beta cell kinome by glucagon-like peptide-1 receptor biased agonism.
Xiao J; El Eid L; Buenaventura T; Boutry R; Bonnefond A; Jones B; Rutter GA; Froguel P; Tomas A
Diabetes Obes Metab; 2023 Aug; 25(8):2105-2119. PubMed ID: 37039251
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 receptors in nucleus accumbens, ventral hippocampus, and lateral septum reduce alcohol reinforcement in mice.
Allingbjerg ML; Hansen SN; Secher A; Thomsen M
Exp Clin Psychopharmacol; 2023 Jun; 31(3):612-620. PubMed ID: 36480394
[TBL] [Abstract][Full Text] [Related]
19. Dietary salt promotes cognition impairment through GLP-1R/mTOR/p70S6K signaling pathway.
Yang X; Liu S; Wang C; Fan H; Zou Q; Pu Y; Cai Z
Sci Rep; 2024 Apr; 14(1):7970. PubMed ID: 38575652
[TBL] [Abstract][Full Text] [Related]
20. Amisulpride attenuates 5-fluorouracil-induced cognitive deficits via modulating hippocampal Wnt/GSK-3β/β-catenin signaling in Wistar rats.
Raafat RS; Habib MZ; AbdElfattah AA; Olama NK; Abdelraouf SM; Hendawy N; Kamal KA; Nawishy SA; Aboul-Fotouh S
Int Immunopharmacol; 2023 Nov; 124(Pt A):110945. PubMed ID: 37716161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
